Target intelligence / Profile preview

Troponin T3, fast skeletal type (TNNT3)

Target
TNNT3
Molecular classification
Other (regulatory protein of the sarcomere), Thin filament-associated protein, Structural protein (muscle system)
01

Overview

Troponin T3, fast skeletal type, encoded by the TNNT3 gene, is a protein found exclusively in fast-twitch skeletal muscle fibers where it forms part of the troponin complex, a central regulator of calcium-mediated muscle contraction. Troponin T3 (fTnT) binds both the troponin complex and tropomyosin, anchoring and functionally linking these protein structures to the actin thin filament of the sarcomere. In response to a rise in calcium concentration, Troponin T3 coordinates changes in the troponin complex, enabling actin–myosin interaction and subsequent muscle contraction. TNNT3 is subject to extensive alternative splicing, generating developmentally and functionally distinct isoforms that fine-tune muscle physiology. Mutations in the TNNT3 gene cause congenital diseases such as distal arthrogryposis and Sheldon-Hall syndrome, underscoring its critical role in musculoskeletal development and function. Current research also links aberrant TNNT3 splicing to some myotonic dystrophies and suggests additional roles for TNNT3 in nuclear genetic regulation in muscle[1][2][3][4].

Other names
troponin T type 3 (skeletal, fast)fast skeletal muscle troponin TTNNT3fTnTbeta TnTFDA2B (in reference to disease association)troponin T, fast skeletal muscletroponin-T3, skeletal, fast
02

Mechanism of action

Not applicable (no direct drugs targeting troponin T3). However, generally, the troponin complex is targeted by some research agents or diagnostics for muscle disease but TNNT3 itself is not a drug target.

03

Biological functions

Regulation of muscle contractionCalcium-dependent signaling in muscle fibersTroponin complex assemblySarcomeric structural integrityTranscriptional regulation (recent findings suggest nuclear shuttling in muscle cells)
04

Disease associations

Distal arthrogryposis multiplex congenita type 2B (DA2B)Sheldon-Hall syndromeMyotonic dystrophy (via alternative splicing defects)
05

Safety considerations

Genetic mutations in TNNT3 are linked to congenital contracture syndromes (e.g., DA2B, Sheldon-Hall syndrome), impacting muscle development and functionThere are no noted safety concerns relevant to pharmacological intervention, as it is not directly drug-targeted
06

Biomarkers

TNNT3 mutations may serve as a diagnostic marker for distal arthrogryposis multiplex congenita type 2B and Sheldon-Hall syndromeAltered splicing patterns in muscle disease contexts

Beyond the preview

Go deeper on Troponin T3, fast skeletal type (TNNT3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Troponin T3, fast skeletal type (TNNT3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call